Ami Organics Ltd
NSE:AMIORG

Watchlist Manager
Ami Organics Ltd Logo
Ami Organics Ltd
NSE:AMIORG
Watchlist
Price: 1 327.4 INR 8.78% Market Closed
Market Cap: 108.7B INR

AMIORG's latest stock split occurred on Apr 25, 2025

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, AMIORG traded at 2202.5 per share. Afterward, the share price was about 1069.8.

The adjusted shares began trading on Apr 25, 2025. This was the only stock split in AMIORG's history.

Last Splits:
Apr 25, 2025
2-for-1
Pre-Split Price
1 101.25 2 202.5
Post-Split Price
1 069.8
Before
After
Last Splits:
Apr 25, 2025
2-for-1

Ami Organics Ltd
Stock Splits History

AMIORG Stock Splits Timeline
Apr 25, 2025
Apr 25, 2025
Split 2-for-1
x2
Pre-Split Price
1 101.25 2 202.5
Post-Split Price
1 069.8
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.5 8.5 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 6, 2026
Itochu Corp
F:IOC0
10-for-1
x10
1060 106 EUR N/A
Load More

Ami Organics Ltd
Glance View

Market Cap
108.7B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
1 053.42 INR
Overvaluation 21%
Intrinsic Value
Price
Back to Top